Pathstone Family Office’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-38,488
Closed -$284K 1293
2023
Q1
$284K Sell
38,488
-38,488
-50% -$284K ﹤0.01% 935
2022
Q4
$56.6K Hold
76,976
﹤0.01% 1458
2022
Q3
$248K Buy
76,976
+40,715
+112% +$131K ﹤0.01% 1272
2022
Q2
$148K Buy
+36,261
New +$148K ﹤0.01% 973